The acrylamide (S)-1 differentially affects Kv7 (KCNQ) potassium channels

Neuropharmacology

Volumn 51, Issue 6, 2006, Pages 1068-1077

  Bentzen, Bo Hjorth ^a   Schmitt, Nicole ^a   Calloe, Kirstine ^a   Dalby Brown, William ^b   Grunnet, Morten ^a,b   Olesen, Søren Peter ^a,b  

^a DANISH NATIONAL RESEARCH FOUNDATION   (Denmark)

^b NEUROSEARCH A S   (Denmark)

Author keywords

Effector site; KCNQ channels; Kv7; M current; Potassium channel

Indexed keywords

3 (5 CHLORO 2 METHOXYPHENYL) 3 FLUORO 2,3 DIHYDRO 6 TRIFLUOROMETHYL 1H INDOL 2 ONE; ACRYLAMIDE DERIVATIVE; N [1 (3 MORPHOLIN 4 YL PHENYL)ETHYL] 3 PHENYLACRYLAMIDE; POTASSIUM CHANNEL; POTASSIUM CHANNEL KCNQ; POTASSIUM CHANNEL STIMULATING AGENT; RETIGABINE; TRYPTOPHAN; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTRIC CURRENT; ELECTRODE; FEMALE; HUMAN; HUMAN CELL; NONHUMAN; OOCYTE; PRIORITY JOURNAL; RECORDING; VOLTAGE CLAMP; XENOPUS LAEVIS;

ACRYLAMIDES; ALGORITHMS; ANIMALS; BINDING SITES; DNA, COMPLEMENTARY; ELECTROPHYSIOLOGY; HUMANS; KCNQ POTASSIUM CHANNELS; KCNQ1 POTASSIUM CHANNEL; KCNQ2 POTASSIUM CHANNEL; KINETICS; MORPHOLINES; NEURONS; OOCYTES; PATCH-CLAMP TECHNIQUES; POINT MUTATION; TRYPTOPHAN; XENOPUS LAEVIS;

EID: 33750614291     PISSN: 00283908     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuropharm.2006.07.001     Document Type: Article

References (25)

1. Barhanin J., Lesage F., Guillemare E., Fink M., Lazdunski M., and Romey G. K(V)LQT1 and lsK (minK) proteins associate to form the I(Ks) cardiac potassium current. Nature 384 (1996) 78-80
2. Biervert C., Schroeder B.C., Kubisch C., Berkovic S.F., Propping P., Jentsch T.J., and Steinlein O.K. A potassium channel mutation in neonatal human epilepsy. Science 279 (1998) 403-406
3. Brown B.S., and Yu S.P. Modulation and genetic identification of the M channel. Prog. Biophys. Mol. Biol. 73 (2000) 135-166
4. Charlier C., Singh N.A., Ryan S.G., Lewis T.B., Reus B.E., Leach R.J., and Leppert M. A pore mutation in a novel KQT-like potassium channel gene in an idiopathic epilepsy family. Nat. Genet. 18 (1998) 53-55
5. Grunnet M., Jensen B.S., Olesen S.P., and Klaerke D.A. Apamin interacts with all subtypes of cloned small-conductance Ca2+-activated K+ channels. Pflugers Arch. 441 (2001) 544-550
6. Jentsch T.J. Neuronal KCNQ potassium channels: physiology and role in disease. Nat. Rev. Neurosci. 1 (2000) 21-30
7. Jespersen T., Grunnet M., Angelo K., Klaerke D.A., and Olesen S.P. Dual-function vector for protein expression in both mammalian cells and Xenopus laevis oocytes. Biotechniques 32 (2002) 536-540
8. Kubisch C., Schroeder B.C., Friedrich T., Lutjohann B., El-Amraoui A., Marlin S., Petit C., and Jentsch T.J. KCNQ4, a novel potassium channel expressed in sensory outer hair cells, is mutated in dominant deafness. Cell 96 (1999) 437-446
9. Lerche C., Scherer C.R., Seebohm G., Derst C., Wei A.D., Busch A.E., and Steinmeyer K. Molecular cloning and functional expression of KCNQ5, a potassium channel subunit that may contribute to neuronal M-current diversity. J. Biol. Chem. 275 (2000) 22395-22400
10. Li Y., Gamper N., and Shapiro M.S. Single-channel analysis of KCNQ K+ channels reveals the mechanism of augmentation by a cysteine-modifying reagent. J. Neurosci. 24 (2004) 5079-5090
11. McCrossan Z.A., and Abbott G.W. The MinK-related peptides. Neuropharmacology 47 (2004) 787-821
12. Sanguinetti M.C., Curran M.E., Zou A., Shen J., Spector P.S., Atkinson D.L., and Keating M.T. Coassembly of K(V)LQT1 and minK (IsK) proteins to form cardiac I(Ks) potassium channel. Nature 384 (1996) 80-83
13. Schenzer A., Friedrich T., Pusch M., Saftig P., Jentsch T.J., Grotzinger J., and Schwake M. Molecular determinants of KCNQ (Kv7) K+ channel sensitivity to the anticonvulsant retigabine. J. Neurosci. 25 (2005) 5051-5060
14. Schroder R.L., Jespersen T., Christophersen P., Strobaek D., Jensen B.S., and Olesen S.P. KCNQ4 channel activation by BMS-204352 and retigabine. Neuropharmacology 40 (2001) 888-898
15. Schroeder B.C., Hechenberger M., Weinreich F., Kubisch C., and Jentsch T.J. KCNQ5, a novel potassium channel broadly expressed in brain, mediates M-type currents. J. Biol. Chem. 275 (2000) 24089-24095
16. Selyanko A.A., Hadley J.K., and Brown D.A. Properties of single M-type KCNQ2/KCNQ3 potassium channels expressed in mammalian cells. J. Physiol. 534 (2001) 15-24
17. Singh N.A., Charlier C., Stauffer D., DuPont B.R., Leach R.J., Melis R., Ronen G.M., Bjerre I., Quattlebaum T., Murphy J.V., McHarg M.L., Gagnon D., Rosales T.O., Peiffer A., Anderson V.E., and Leppert M. A novel potassium channel gene, KCNQ2, is mutated in an inherited epilepsy of newborns. Nat. Genet. 18 (1998) 25-29
18. Splawski I., Tristani-Firouzi M., Lehmann M.H., Sanguinetti M.C., and Keating M.T. Mutations in the hminK gene cause long QT syndrome and suppress IKs function. Nat. Genet. 17 (1997) 338-340
19. Tatulian L., and Brown D.A. Effect of the KCNQ potassium channel opener retigabine on single KCNQ2/3 channels expressed in CHO cells. J. Physiol. 549 (2003) 57-63
20. Tatulian L., Delmas P., Abogadie F.C., and Brown D.A. Activation of expressed KCNQ potassium currents and native neuronal M-type potassium currents by the anti-convulsant drug retigabine. J. Neurosci. 21 (2001) 5535-5545
21. Wang Q., Curran M.E., Splawski I., Burn T.C., Millholland J.M., VanRaay T.J., Shen J., Timothy K.W., Vincent G.M., de J.T., Schwartz P.J., Toubin J.A., Moss A.J., Atkinson D.L., Landes G.M., Connors T.D., and Keating M.T. Positional cloning of a novel potassium channel gene: KVLQT1 mutations cause cardiac arrhythmias. Nat. Genet. 12 (1996) 17-23
22. Wang H.S., Pan Z., Shi W., Brown B.S., Wymore R.S., Cohen I.S., Dixon J.E., and McKinnon D. KCNQ2 and KCNQ3 potassium channel subunits: molecular correlates of the M-channel. Science 282 (1998) 1890-1893
23. Wang H.S., Brown B.S., McKinnon D., and Cohen I.S. Molecular basis for differential sensitivity of KCNQ and I(Ks) channels to the cognitive enhancer XE991. Mol. Pharmacol. 57 (2000) 1218-1223
24. Wu Y.J., Boissard C.G., Greco C., Gribkoff V.K., Harden D.G., He H., L'Heureux A., Kang S.H., Kinney G.G., Knox R.J., Natale J., Newton A.E., Lehtinen-Oboma S., Sinz M.W., Sivarao D.V., Starrett Jr. J.E., Sun L.Q., Tertyshnikova S., Thompson M.W., Weaver D., Wong H.S., Zhang L., and Dworetzky S.I. (S)-N-[1-(3-morpholin-4-ylphenyl)ethyl]- 3-phenylacrylamide: an orally bioavailable KCNQ2 opener with significant activity in a cortical spreading depression model of migraine. J. Med. Chem. 46 (2003) 3197-3200
25. Wuttke T.V., Seebohm G., Bail S., Maljevic S., and Lerche H. The new anticonvulsant retigabine favors voltage-dependent opening of the Kv7.2 (KCNQ2) channel by binding to its activation gate. Mol. Pharmacol. 67 (2005) 1009-1017